the hypolipidemic as well as other laboratory and clinical effects of halofenate , clofibrate , and placebo were compared in 29 patients with type iv hyperlipoproteinemia in a double-blind , controlled , therapeutic trial of 1 yr duration .
C0009002
clofibrate
C0020476
hyperlipoproteinemia